News
Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...
Qure divested for $25M, advanced AMT-130 with FDA approvals, and building infrastructure. A strong balance sheet backs ...
Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic ...
Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.
Genetic defects are exceedingly common, which is not surprising considering just how many cells make up our bodies, including our reproductive cells. While most of these defects have no or only ...
3d
Clinical Trials Arena on MSNPatient dies in Rocket’s Phase II Danon disease gene therapy trialA patient has died in a pivotal Phase II trial of Rocket Pharmaceuticals’ gene therapy for Danon disease after suffering a ...
3d
Medindia on MSNNext-Gen Nasal Spray Gene Therapy Targets Lung Diseases and COVID-19Scientists engineered a way to deliver genes directly to lung and airway cells using a nasal spray * AAV.CCP.16 -// a viral ...
For gene therapy to work well, therapeutic molecules need to be efficiently delivered to the correct locations in the body -- a job commonly given to adeno-associated viruses (AAV). To improve the AAV ...
Scientists working at the NIH’s BRAIN Initiative have created new viral vectors that one day could lead to gene therapies for ...
Scientists in Philadelphia have, for the first time, created a life-saving solution for a 9-month-old baby—one that could now ...
Explore how CRISPR could become a powerful antiviral tool against HIV, Hepatitis B, HPV, and more, based on emerging research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results